David C. Hanley serves as Executive at Nuvation Bio Inc., where they oversee executive responsibilities. Since joining the company, David C. Hanley has executed 2 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 19, 2025 involved selling 200,000 shares valued at $1.4M.
David C. Hanley currently holds 24,000 shares of Nuvation Bio Inc. (NUVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David C. Hanley has been a net seller of NUVB stock. They have purchased $0 and sold $1.4M worth of shares.
David C. Hanley's most recent insider trade was on Nov 19, 2025, when they sold 200,000 shares at $7.14 per share.
Get notified when new Form 4 filings are submitted
| $1.87 |
| Discretionary |